Evidence map›Paper›PMID 32201449›Full record

SynthesisIndian journal of pharmacology

Drug targets for corona virus: A systematic review.

Manisha Prajapat, Phulen Sarma, Nishant Shekhar, Pramod Avti, Shweta Sinha, Hardeep Kaur, Subodh Kumar, Anusuya Bhattacharyya, Harish Kumar, Seema Bansal and 1 more

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Indian journal of pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Manisha PrajapatDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Phulen SarmaDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Nishant ShekharDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pramod AvtiDepartment of Biophysics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Shweta SinhaDepartment of Parasitology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Hardeep KaurDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Subodh KumarDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Anusuya BhattacharyyaDepartments of Ophthalmology, Government Medical College and Hospital, Chandigarh, India.
Harish KumarDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Seema BansalDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Bikash MedhiDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2019-novel coronavirus (nCoV) is a major source of disaster in the 21

Indexed as

Drug DesignBetacoronavirusCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentHumansMiddle East Respiratory Syndrome CoronavirusMolecular Targeted TherapyPneumonia, ViralSARS-CoV-2Severe acute respiratory syndrome-related coronavirusViral ProteinsViral ProteinsCoronavirusdrug targetsMiddle East respiratory syndromesevere acute respiratory syndrome

Identifiers

PMID32201449
PMCPMC7074424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.